Among the TIL, a hi PD-1 and FoxP3+ cell populations have been described in DLBCL microenvironment and the number of PD-1hi and FoxP3+ cells, as well as total CD4+ T-cells are associated with improved clinical outcome [80]. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.